中药消癌平针剂经肝动脉介入治疗转移性肝癌的临床研究

Clinical Study on “Cancer Eliminating Injection” by Intervertion Therapy Through Hepatic Artery in Metastatic Liver Cancer

用中药消癌平针剂经肝动脉介入治疗转移性肝癌３１例，并与化疗介入２２例作对照。结果：临床总有效率分别为７０－９７％、４０－９１％，两组比较Ｐ＜０．０１。肿瘤的ＰＲ＋ＮＣ分别为６７－７４％、６３－６３％，两组比较Ｐ＞０．０５。治疗平均生存天数为２２６－０７天、１１８－３８天，两组比较Ｐ＜０．０１；ＫＰＳ评分总有效率分别为８０－６５％、５０％，两组比较Ｐ＜０．０５。提示中药消癌平可改善临床症状和体征，提高患者的生存质量，缩小或稳定病灶，延长生存期。

cases of metastatic liver cancer were treated with “Cancer Eliminating Injection” by intervention therapy through the hepatic artery,together with 22 cases treated by chemotherapeutic intervention as control.The results revealed that the total effective rates were respectively 70.97% and 40.91%,with a significant difference between two groups( P <0.01);that PR+NC were respectively 67.74% and 63.63%,with no significant difference between two groups ( P >0.05);that the average survival days were respectively 226.07 and 118.38,with a significant difference between two groups ( P <0.01) and that the total effective rate by KPS were 80.65% and 50% respectively,with a marked difference between two groups.The results showed that Chinese herbal “Cancer Eliminating Injection” could improve the clinical symptoms and signs,enhance the patients life quality,diminish or stabilize the focus and prolong the survival time.